TELA TELA Bio, Inc. Stock Quote

TELA [NASD]

Index	-	P/E	-	EPS (ttm)	-2.30	Insider Own	2.50%	Shs Outstand	14.54M	Perf Week	-5.71%
Market Cap	119.88M	Forward P/E	-	EPS next Y	-1.50	Insider Trans	459.08%	Shs Float	12.76M	Perf Month	-7.89%
Income	-33.30M	PEG	-	EPS next Q	-0.59	Inst Own	94.80%	Short Float	1.49%	Perf Quarter	-27.08%
Sales	29.50M	P/S	4.06	EPS this Y	-3.30%	Inst Trans	12.26%	Short Ratio	5.12	Perf Half Y	-32.43%
Book/sh	0.69	P/B	12.68	EPS next Y	25.30%	ROA	-55.30%	Target Price	19.25	Perf Year	-33.31%
Cash/sh	2.41	P/C	3.63	EPS next 5Y	-	ROE	-155.10%	52W Range	7.23 - 16.53	Perf YTD	-31.64%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-57.10%	52W High	-47.06%	Beta	-
Dividend %	-	Quick Ratio	3.30	Sales past 5Y	-	Gross Margin	63.90%	52W Low	21.02%	ATR	0.66
Employees	123	Current Ratio	4.10	Sales Q/Q	39.00%	Oper. Margin	-	RSI (14)	38.58	Volatility	13.68% 6.79%
Optionable	No	Debt/Eq	3.17	EPS Q/Q	-32.60%	Profit Margin	-	Rel Volume	0.79	Prev Close	8.61
Shortable	Yes	LT Debt/Eq	3.17	Earnings	May 10 AMC	Payout	-	Avg Volume	37.04K	Price	8.75
Recom	1.50	SMA20	-4.97%	SMA50	-17.50%	SMA200	-28.22%	Volume	29,275	Change	1.63%

Dec-03-19

Initiated

Piper Jaffray

Overweight

Dec-03-19

Initiated

JMP Securities

Mkt Outperform

Dec-03-19

Initiated

Jefferies

Buy

Dec-03-19

Initiated

Canaccord Genuity

Buy

May-17-22 08:25AM	The past year for TELA Bio (NASDAQ:TELA) investors has not been profitable Simply Wall St.
May-10-22 05:45PM	TELA Bio, Inc. (TELA) Reports Q1 Loss, Tops Revenue Estimates Zacks
04:01PM	TELA Bio Reports First Quarter 2022 Financial Results GlobeNewswire
May-09-22 07:00AM	TELA Bio to Participate in Upcoming 2022 H.C. Wainwright Annual Global Investment Conference GlobeNewswire
May-05-22 05:55PM	Guardant Health (GH) Reports Q1 Loss, Lags Revenue Estimates Zacks
May-02-22 04:11AM	Strength Seen in Cytokinetics (CYTK): Can Its 11.5% Jump Turn into More Strength? Zacks
Apr-29-22 05:00PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Apr-26-22 07:00AM	TELA Bio to Announce First Quarter 2022 Financial Results GlobeNewswire
Apr-18-22 07:00AM	TELA Bio Appoints D. Taylor Ocasio as General Counsel GlobeNewswire -5.00%
Mar-30-22 07:00AM	TELA Bio to Participate in Upcoming Needham & Co. 21st Annual Healthcare Virtual Conference GlobeNewswire
Mar-21-22 05:15PM	TELA Bio, Inc. (TELA) Reports Q4 Loss, Tops Revenue Estimates Zacks
04:01PM	TELA Bio Reports Fourth Quarter and Full Year 2021 Financial Results GlobeNewswire
Mar-16-22 07:00AM	TELA Bio to Participate in Upcoming Canaccord Genuity Musculoskeletal Conference in Chicago, IL GlobeNewswire
Mar-08-22 12:42PM	Tela Bio begins transformation with plans for new products and hiring American City Business Journals
09:21AM	Is TELA Bio (NASDAQ:TELA) A Risky Investment? Simply Wall St.
Mar-07-22 04:01PM	TELA Bio to Announce Fourth Quarter and Full Year 2021 Financial Results GlobeNewswire
Mar-03-22 08:35AM	Fulcrum Therapeutics, Inc. (FULC) Reports Q4 Loss, Tops Revenue Estimates Zacks
07:00AM	TELA Bio Announces U.S. Commercial Launch of SiteGuard No Rinse Antimicrobial Solution GlobeNewswire
Feb-28-22 05:45PM	Fate Therapeutics (FATE) Reports Q4 Loss, Tops Revenue Estimates Zacks
Feb-25-22 04:01PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Feb-24-22 07:00PM	OYSTER PT PHARM (OYST) Reports Q4 Loss, Tops Revenue Estimates Zacks
Dec-08-21 11:25AM	TELA Bio (NASDAQ:TELA) shareholders have endured a 26% loss from investing in the stock a year ago Simply Wall St.
Nov-11-21 11:30AM	TELA Bio, Inc. (TELA) Q3 2021 Earnings Call Transcript Motley Fool
Nov-10-21 05:35PM	TELA Bio, Inc. (TELA) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:01PM	TELA Bio Reports Strong Third Quarter 2021 Revenues Reflecting Continued Growth Driven by Increased Demand GlobeNewswire
Nov-09-21 07:00AM	TELA Bio Announces Publication of 12-Month Results from the BRAVO Study with Continued Positive Outcomes Through 24 months GlobeNewswire
Nov-08-21 07:00AM	TELA Bio to Participate in Three Upcoming Conferences GlobeNewswire
Nov-03-21 03:01PM	Will TELA Bio, Inc. (TELA) Report Negative Q3 Earnings? What You Should Know Zacks
Nov-01-21 07:00AM	TELA Bio and Next Science Enter into Exclusive Distribution Agreement in the Plastic Reconstructive Market for Advanced Anti-Biofilm Surgical Wash GlobeNewswire
Oct-27-21 04:01PM	TELA Bio to Announce Third Quarter 2021 Financial Results GlobeNewswire
Sep-27-21 07:00AM	TELA Bio Appoints Roberto Cuca as Chief Operating Officer and Chief Financial Officer GlobeNewswire
Sep-24-21 09:33AM	10 Best Healthcare Stocks to Buy According to Matthew Halbowers Pentwater Capital Management Insider Monkey
Sep-13-21 07:00AM	TELA Bio® Announces New Data on Use of OviTex in a Range of Hernia Repair Applications, Including Novel ReBAR (Reinforced Biologic Augmented Repair) Technique GlobeNewswire
Sep-09-21 10:35AM	Is TELA Bio (NASDAQ:TELA) Using Too Much Debt? Simply Wall St.
Aug-16-21 07:00AM	TELA Bio's OviTex® Reinforced Tissue Matrix to be Featured in Three Presentations at SAGES 2021 GlobeNewswire
Aug-11-21 11:00PM	TELA Bio, Inc. (TELA) Q2 2021 Earnings Call Transcript Motley Fool
05:35PM	TELA Bio, Inc. (TELA) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:01PM	TELA Bio Reports Record Second Quarter 2021 Revenues Driven by Increased Demand GlobeNewswire
Aug-04-21 03:00PM	TELA Bio, Inc. (TELA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Aug-03-21 07:00AM	TELA Bio to Participate in Canaccord Genuitys 41st Annual Growth Conference GlobeNewswire
Jul-28-21 07:00AM	TELA Bio to Announce Second Quarter 2021 Financial Results GlobeNewswire
Jul-21-21 08:28AM	NHS Surgeon First in Europe to Implant TELA Bio's OviTex® LPR Reinforced Tissue Matrix GlobeNewswire
Jun-18-21 10:47AM	New Strong Sell Stocks for June 18th Zacks
Jun-14-21 07:00AM	TELA Bio to Participate in Upcoming JMP Securities Life Sciences Conference GlobeNewswire
Jun-02-21 07:00AM	TELA Bio Announces Changes to its Board of Directors GlobeNewswire
06:34AM	TELA Bio's (NASDAQ:TELA) Shareholders Are Down 22% On Their Shares Simply Wall St.
May-25-21 07:00AM	TELA Bio Names Marissa Conrad as Vice President of Clinical and Regulatory Affairs GlobeNewswire
May-21-21 07:00AM	TELA Bio to Participate in Upcoming Investor Conferences GlobeNewswire
May-19-21 07:00AM	TELA Bio Initiates BRAVO II Study of OviTex® for the Robotic Repair of Ventral Hernias GlobeNewswire
May-14-21 06:30AM	TELA Bio, Inc. (TELA) Q1 2021 Earnings Call Transcript Motley Fool +6.24%
May-13-21 06:15PM	TELA Bio, Inc. (TELA) Reports Q1 Loss, Tops Revenue Estimates Zacks
04:02PM	TELA Bio Announces First Quarter 2021 Financial Results GlobeNewswire
02:30PM	TELA Bio Inc to Host Earnings Call ACCESSWIRE
May-06-21 03:01PM	TELA Bio, Inc. (TELA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
May-03-21 11:48AM	TELA Bio Inc. (TELA) Q4 2020 Earnings Call Transcript Motley Fool
Apr-29-21 04:00PM	TELA Bio to Announce First Quarter 2021 Financial Results GlobeNewswire
Mar-24-21 05:25PM	TELA Bio, Inc. (TELA) Reports Q4 Loss, Tops Revenue Estimates Zacks
04:28PM	Recap: TELA Bio Q4 Earnings Benzinga
04:01PM	TELA Bio Announces Fourth Quarter and Full Year 2020 Financial Results GlobeNewswire
02:30PM	TELA Bio Inc to Host Earnings Call ACCESSWIRE
Mar-18-21 07:00AM	TELA Bio Announces 12-Month Analysis from BRAVO Study of OviTex® for Ventral Hernia Repair GlobeNewswire
Mar-02-21 07:00AM	TELA Bio to Report Fourth Quarter and Full Year 2020 Financial Results on March 24, 2021 GlobeNewswire
Feb-12-21 05:16AM	Is TELA Bio (NASDAQ:TELA) Using Too Much Debt? Simply Wall St.
Feb-04-21 07:00AM	TELA Bio to Participate in Upcoming BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference GlobeNewswire
Jan-14-21 07:00AM	TELA Bio Reports Preliminary Results for Fourth Quarter and Full Year 2020 GlobeNewswire
Jan-06-21 07:00AM	TELA Bio to Participate in Upcoming Needham Virtual Growth Conference GlobeNewswire
Jan-05-21 07:00AM	TELA Bio Appoints Renowned Surgeon as Vice President of Clinical Development GlobeNewswire
Dec-09-20 01:32PM	Is TELA A Good Stock To Buy Now? Insider Monkey
Nov-24-20 07:00AM	TELA Bio to Participate in Upcoming Piper Sandler 32nd Annual Virtual Healthcare Conference GlobeNewswire
Nov-11-20 04:34PM	Recap: TELA Bio Q3 Earnings Benzinga
04:05PM	TELA Bio Announces Third Quarter 2020 Financial Results GlobeNewswire
02:30PM	TELA Bio Inc to Host Earnings Call ACCESSWIRE
Nov-10-20 07:00AM	TELA Bio to Participate at Upcoming Investor Conferences GlobeNewswire
Oct-21-20 04:05PM	TELA Bio to Announce Third Quarter 2020 Financial Results and Host Conference Call on November 11, 2020 GlobeNewswire
Sep-25-20 07:00AM	TELA Bio Presents Additional Data from BRAVO Study of OviTex® for Ventral Hernia Repair GlobeNewswire
Sep-02-20 07:00AM	TELA Bio to Participate at Upcoming Conferences GlobeNewswire -5.24%
Aug-12-20 04:05PM	TELA Bio Announces Second Quarter 2020 Financial Results GlobeNewswire
07:29AM	The Daily Biotech Pulse: India Globalization Gets Nod For Alzheimer's Trial, Moderna's Vaccine Deal With US, Cellular Biomedicine To Go Private Benzinga
Jul-30-20 07:00AM	TELA Bio to Participate at the Canaccord Genuity 40th Annual Growth Conference GlobeNewswire
Jul-23-20 05:19PM	TELA Bio to Announce Second Quarter 2020 Financial Results and Host Conference Call on August 12, 2020 GlobeNewswire
Jun-30-20 04:05PM	TELA Bio Announces Closing of Public Offering of Common Stock GlobeNewswire
Jun-25-20 06:42PM	TELA Bio Announces Pricing of Public Offering of Common Stock GlobeNewswire -8.14%
Jun-24-20 08:07AM	The Daily Biotech Pulse: MediciNova On Track For European Patent Win, Partial Clinical Hold Lifted For Innate Pharma, Tela Bio Details Coronavirus Impact Benzinga -6.58%
Jun-23-20 09:35PM	Hedge Funds Cautiously Watching TELA Bio, Inc. (TELA) Insider Monkey
04:17PM	TELA Bio Announces Proposed Public Offering of Common Stock GlobeNewswire
Jun-22-20 07:00AM	TELA Bio, Inc. to Join the Russell 2000® Index GlobeNewswire -7.56%
Jun-15-20 07:00AM	TELA Bio, Inc. Announces Poster Presentations at the 2020 Minimally Invasive Surgery Symposium (MISS) GlobeNewswire +8.42%
May-29-20 07:00AM	TELA Bio to Present at the Jefferies Virtual Healthcare Conference GlobeNewswire
May-12-20 04:05PM	TELA Bio Announces First Quarter 2020 Financial Results GlobeNewswire -10.27%
Apr-28-20 07:00AM	TELA Bio to Announce First Quarter 2020 Financial Results and Host Conference Call on May 12, 2020 GlobeNewswire -12.19%
Apr-23-20 06:30AM	TELA Bio Announces Changes to its Board of Directors GlobeNewswire
Mar-30-20 07:29AM	TELA Bio, Inc. (NASDAQ:TELA) Just Reported And Analysts Have Been Cutting Their Estimates Simply Wall St.
Mar-27-20 07:00AM	TELA Bio Announces Fourth Quarter and Full Year 2019 Financial Results GlobeNewswire
06:00AM	TELA Bio Inc to Host Earnings Call ACCESSWIRE
Mar-11-20 07:00AM	TELA Bio to Announce Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call on March 27, 2020 GlobeNewswire -13.39%
Feb-04-20 04:15PM	TELA Bio Announces Publication of Results from In-Vivo Study Demonstrating Favorable Response to Reinforced Biologics in Hernia Repair GlobeNewswire
Jan-29-20 07:00AM	TELA Bio Announces Appointment of New Chief Commercial Officer GlobeNewswire
Jan-10-20 07:00AM	TELA Bio Announces Preliminary Revenue for Fourth Quarter and Full Year 2019 GlobeNewswire
Dec-18-19 07:00AM	TELA Bio Announces Third Quarter 2019 Financial Results GlobeNewswire +11.46%
Dec-06-19 07:00AM	TELA Bio Awarded Contract with HealthTrust Purchasing Group GlobeNewswire

TELA Bio, Inc., a medical technology company, focuses on the design, development, and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
EW HEALTHCARE PARTNERS FUND 2,		May 16	Buy	8.61	5,000	43,050	3,410,709	May 16 06:22 PM
EW HEALTHCARE PARTNERS FUND 2,		May 13	Buy	8.48	5,000	42,400	3,405,709	May 16 06:22 PM
EW HEALTHCARE PARTNERS FUND 2,		May 12	Buy	8.21	5,000	41,050	3,400,709	May 16 06:22 PM
EW HEALTHCARE PARTNERS FUND 2,		May 11	Buy	8.82	5,000	44,100	3,395,709	May 11 06:19 PM
EW HEALTHCARE PARTNERS FUND 2,		May 10	Buy	9.27	5,000	46,350	3,390,709	May 11 06:19 PM
EW HEALTHCARE PARTNERS FUND 2,		May 09	Buy	9.38	5,000	46,900	3,385,709	May 11 06:19 PM
EW HEALTHCARE PARTNERS FUND 2,		May 06	Buy	9.55	5,000	47,750	3,380,709	May 09 05:17 PM
EW HEALTHCARE PARTNERS FUND 2,		May 05	Buy	9.62	5,000	48,100	3,375,709	May 09 05:17 PM
EW HEALTHCARE PARTNERS FUND 2,		May 04	Buy	9.53	5,000	47,650	3,370,709	May 04 05:53 PM
EW HEALTHCARE PARTNERS FUND 2,		May 03	Buy	9.40	5,000	47,000	3,365,709	May 04 05:53 PM
EW HEALTHCARE PARTNERS FUND 2,		May 02	Buy	9.32	5,000	46,600	3,360,709	May 04 05:53 PM
EW HEALTHCARE PARTNERS FUND 2,		Apr 29	Buy	9.17	5,000	45,850	3,355,709	Apr 29 06:10 PM
EW HEALTHCARE PARTNERS FUND 2,		Apr 28	Buy	9.09	5,000	45,450	3,350,709	Apr 29 06:10 PM
EW HEALTHCARE PARTNERS FUND 2,		Apr 27	Buy	9.05	5,000	45,250	3,345,709	Apr 29 06:10 PM
EW HEALTHCARE PARTNERS FUND 2,		Apr 26	Buy	9.24	10,000	92,400	3,340,709	Apr 27 11:31 AM
EW HEALTHCARE PARTNERS FUND 2,		Apr 25	Buy	9.49	5,000	47,450	3,330,709	Apr 27 11:31 AM
EW HEALTHCARE PARTNERS FUND 2,		Apr 19	Buy	9.84	3,200	31,488	3,325,709	Apr 19 07:01 PM
EW HEALTHCARE PARTNERS FUND 2,		Apr 18	Buy	9.80	5,000	49,000	3,322,509	Apr 19 07:01 PM
EW HEALTHCARE PARTNERS FUND 2,		Apr 14	Buy	10.00	589	5,890	3,317,509	Apr 19 07:01 PM
EW HEALTHCARE PARTNERS FUND 2,		Apr 01	Buy	11.45	684	7,832	3,316,920	Apr 04 12:59 PM
EW HEALTHCARE PARTNERS FUND 2,		Mar 31	Buy	11.54	5,000	57,700	3,316,236	Apr 04 12:59 PM
EW HEALTHCARE PARTNERS FUND 2,		Mar 30	Buy	11.65	2,645	30,814	3,311,236	Mar 31 12:01 PM
EW HEALTHCARE PARTNERS FUND 2,		Mar 29	Buy	11.65	3,052	35,556	3,308,591	Mar 31 12:01 PM
EW HEALTHCARE PARTNERS FUND 2,		Mar 22	Buy	11.65	136	1,584	3,305,539	Mar 24 05:57 PM
EW HEALTHCARE PARTNERS FUND 2,		Mar 16	Buy	11.65	2,331	27,156	3,305,403	Mar 16 08:28 PM
EW HEALTHCARE PARTNERS FUND 2,		Mar 15	Buy	11.65	100	1,165	3,303,072	Mar 16 08:28 PM
EW HEALTHCARE PARTNERS FUND 2,		Mar 14	Buy	11.68	3,473	40,565	3,302,972	Mar 16 08:28 PM
EW HEALTHCARE PARTNERS FUND 2,		Feb 24	Buy	11.74	5,572	65,415	3,299,499	Feb 24 06:55 PM
EW HEALTHCARE PARTNERS FUND 2,		Feb 23	Buy	11.75	750,657	8,820,220	3,293,927	Feb 24 06:55 PM
EW HEALTHCARE PARTNERS FUND 2,		Feb 22	Buy	11.74	3,579	42,017	2,543,270	Feb 24 06:55 PM
EW HEALTHCARE PARTNERS FUND 2,		Feb 18	Buy	11.75	2,520	29,610	2,539,691	Feb 18 08:48 PM
EW HEALTHCARE PARTNERS FUND 2,		Feb 17	Buy	11.73	6,810	79,881	2,537,171	Feb 18 08:48 PM
EW HEALTHCARE PARTNERS FUND 2,		Feb 16	Buy	11.72	10,000	117,200	2,530,361	Feb 18 08:48 PM
EW HEALTHCARE PARTNERS FUND 2,		Feb 15	Buy	11.75	29	341	2,520,361	Feb 16 04:24 PM
EW HEALTHCARE PARTNERS FUND 2,		Feb 14	Buy	11.75	10	118	2,520,332	Feb 16 04:24 PM
EW HEALTHCARE PARTNERS FUND 2,		Feb 11	Buy	11.74	7,082	83,143	2,520,322	Feb 14 05:50 PM
EW HEALTHCARE PARTNERS FUND 2,		Feb 10	Buy	11.75	520	6,110	2,513,240	Feb 14 05:50 PM
EW HEALTHCARE PARTNERS FUND 2,		Feb 09	Buy	11.75	1,327	15,592	2,512,720	Feb 10 05:27 PM
EW HEALTHCARE PARTNERS FUND 2,		Feb 08	Buy	11.75	500	5,875	2,511,393	Feb 10 05:27 PM
EW HEALTHCARE PARTNERS FUND 2,		Jan 31	Buy	11.74	1,950	22,893	2,510,893	Feb 01 01:26 PM
EW HEALTHCARE PARTNERS FUND 2,		Jan 28	Buy	11.33	5,000	56,650	2,508,943	Feb 01 01:26 PM
EW HEALTHCARE PARTNERS FUND 2,		Jan 27	Buy	11.51	5,000	57,550	2,503,943	Jan 28 06:06 PM
EW HEALTHCARE PARTNERS FUND 2,		Jan 26	Buy	11.74	4,993	58,618	2,498,943	Jan 28 06:06 PM
EW HEALTHCARE PARTNERS FUND 2,		Jan 25	Buy	11.92	3,846	45,844	2,493,950	Jan 26 11:49 AM
EW HEALTHCARE PARTNERS FUND 2,		Jan 24	Buy	11.68	5,000	58,400	2,490,104	Jan 26 11:49 AM
EW HEALTHCARE PARTNERS FUND 2,		Jan 14	Buy	12.00	567,467	6,809,604	2,485,104	Jan 19 12:52 PM
EW HEALTHCARE PARTNERS FUND 2,		Jan 12	Buy	12.50	5,000	62,500	1,917,637	Jan 14 05:24 PM
EW HEALTHCARE PARTNERS FUND 2,		Jan 11	Buy	12.38	5,000	61,900	1,912,637	Jan 12 05:25 PM
EW HEALTHCARE PARTNERS FUND 2,		Jan 10	Buy	12.46	1,409	17,556	1,907,637	Jan 12 05:25 PM
EW HEALTHCARE PARTNERS FUND 2,		Dec 31	Buy	12.46	5,928	73,863	1,906,228	Jan 04 09:24 PM
EW HEALTHCARE PARTNERS FUND 2,		Dec 20	Buy	12.22	4,300	52,546	1,900,300	Dec 22 05:43 PM
EW HEALTHCARE PARTNERS FUND 2,		Dec 16	Buy	12.45	5,050	62,872	1,896,000	Dec 17 05:40 PM
EW HEALTHCARE PARTNERS FUND 2,		Dec 15	Buy	12.43	5,000	62,150	1,890,950	Dec 17 05:40 PM
EW HEALTHCARE PARTNERS FUND 2,		Dec 14	Buy	12.33	10,000	123,300	1,885,950	Dec 14 05:50 PM
EW HEALTHCARE PARTNERS FUND 2,		Dec 10	Buy	12.49	1,387	17,324	1,875,950	Dec 14 05:50 PM
EW HEALTHCARE PARTNERS FUND 2,		Dec 08	Buy	12.39	1,425	17,656	1,874,563	Dec 08 06:47 PM
EW HEALTHCARE PARTNERS FUND 2,		Dec 07	Buy	12.32	11,148	137,343	1,873,138	Dec 08 06:47 PM
EW HEALTHCARE PARTNERS FUND 2,		Dec 06	Buy	12.39	10,000	123,900	1,861,990	Dec 08 06:47 PM
Cuca Roberto	COO and CFO	Dec 02	Buy	12.67	1,351	17,117	4,392	Dec 03 04:20 PM
Cuca Roberto	COO and CFO	Dec 01	Buy	12.64	1,780	22,499	3,041	Dec 01 08:25 PM
Cuca Roberto	COO and CFO	Nov 30	Buy	12.43	838	10,416	1,261	Dec 01 08:25 PM
Cuca Roberto	COO and CFO	Nov 29	Buy	12.60	423	5,330	423	Dec 01 08:25 PM
EW HEALTHCARE PARTNERS FUND 2,		Nov 23	Buy	12.49	516	6,445	1,851,990	Nov 23 05:40 PM
EW HEALTHCARE PARTNERS FUND 2,		Nov 22	Buy	12.49	3,295	41,155	1,851,474	Nov 23 05:40 PM
EW HEALTHCARE PARTNERS FUND 2,		Nov 18	Buy	12.41	4,419	54,840	1,848,179	Nov 19 06:47 PM
EW HEALTHCARE PARTNERS FUND 2,		Nov 17	Buy	12.50	1,000	12,500	1,843,760	Nov 19 06:47 PM
EW HEALTHCARE PARTNERS FUND 2,		Nov 10	Buy	12.50	1,000	12,500	1,842,760	Nov 12 07:18 PM
EW HEALTHCARE PARTNERS FUND 2,		Oct 27	Buy	12.43	5,088	63,244	1,841,760	Oct 29 04:13 PM
EW HEALTHCARE PARTNERS FUND 2,		Oct 20	Buy	12.42	2,090	25,958	1,836,672	Oct 22 05:40 PM
EW HEALTHCARE PARTNERS FUND 2,		Oct 13	Buy	12.50	200	2,500	1,834,582	Oct 13 06:20 PM
EW HEALTHCARE PARTNERS FUND 2,		Oct 11	Buy	12.50	283	3,538	1,834,382	Oct 13 06:20 PM
EW HEALTHCARE PARTNERS FUND 2,		Oct 06	Buy	12.50	110	1,375	1,834,099	Oct 08 12:57 PM
EW HEALTHCARE PARTNERS FUND 2,		Sep 21	Buy	12.60	695	8,757	1,833,989	Sep 23 06:38 PM
EW HEALTHCARE PARTNERS FUND 2,		Sep 20	Buy	12.58	924	11,624	1,833,294	Sep 21 05:41 PM
EW HEALTHCARE PARTNERS FUND 2,		Sep 17	Buy	12.61	322	4,060	1,832,370	Sep 21 05:41 PM
EW HEALTHCARE PARTNERS FUND 2,		Sep 14	Buy	12.27	10,000	122,700	1,822,048	Sep 15 01:23 PM
EW HEALTHCARE PARTNERS FUND 2,		Sep 13	Buy	12.43	115	1,429	1,812,048	Sep 15 01:23 PM
EW HEALTHCARE PARTNERS FUND 2,		Sep 13	Buy	12.43	10,000	124,300	1,832,048	Sep 17 04:52 PM
EW HEALTHCARE PARTNERS FUND 2,		Sep 10	Buy	12.31	14,436	177,707	1,811,933	Sep 13 02:55 PM
EW HEALTHCARE PARTNERS FUND 2,		Sep 09	Buy	12.46	13,087	163,064	1,797,497	Sep 13 02:55 PM
EW HEALTHCARE PARTNERS FUND 2,		Sep 08	Buy	13.24	47	622	1,784,410	Sep 09 01:36 PM
EW HEALTHCARE PARTNERS FUND 2,		Sep 07	Buy	12.77	131	1,673	1,784,363	Sep 09 01:36 PM
EW HEALTHCARE PARTNERS FUND 2,		Jun 14	Buy	12.50	79,970	999,625	1,784,232	Jun 16 12:17 PM
EW HEALTHCARE PARTNERS FUND 2,		Jun 07	Buy	12.99	10,000	129,900	1,704,262	Jun 09 08:20 PM
EW HEALTHCARE PARTNERS FUND 2,		Jun 03	Buy	13.17	201	2,647	1,694,262	Jun 07 04:42 PM
EW HEALTHCARE PARTNERS FUND 2,		May 24	Buy	13.31	1,278	17,010	1,694,061	May 27 03:11 PM
EW HEALTHCARE PARTNERS FUND 2,		May 21	Buy	13.30	1,549	20,602	1,692,783	May 27 03:11 PM
EW HEALTHCARE PARTNERS FUND 2,		May 20	Buy	13.30	8,525	113,382	1,691,234	May 20 07:01 PM
EW HEALTHCARE PARTNERS FUND 2,		May 19	Buy	13.44	450	6,048	1,682,709	May 20 07:01 PM
EW HEALTHCARE PARTNERS FUND 2,		May 18	Buy	13.30	3,546	47,162	1,682,259	May 20 07:01 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience